Author

M. Guzel

University of Tennessee at Knoxville

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:database / resource· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:metagenomics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A-S. Andrei· 1 shared A. Akdemir· 1 shared A. De Santiago· 1 shared A. Kayabolen· 1 shared A. M. Gada· 1 shared A. Olkan· 1 shared A. Ozcan· 1 shared Aleksandra Petrović FabijaniD· 1 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A-S. Andrei

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A roadmap for fair reuse of public microbiome data

Laura A. Hug, Roland Hatzenpichler, Cristina Moraru, André Soares, Folker Meyer, Anke Heyder, Rehab Z. Abdallah, Ammar Abdalrahem, Nafi’u Abdulkadir, Ibukun Modupe Adesiyan, Lauren V. Alteio, Karthik Anantharaman, Rika E. Anderson, A-S. Andrei, Juan Antonio Baeza, , Matthew Kellom

The paper proposes a roadmap for fair reuse of public microbiome data by introducing a Data Reuse Information tag (DRI) to facilitate communication between data creators and consumers.

Nature Microbiology · Sep 26, 2025Peer-reviewedMicrobiology

The neutralization effect of Montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies

S. Durdagi, T. Avsar, M. D. Orhan, M. Serhatli, B. K. Balcioglu, H. U. Ozturk, A. Kayabolen, Y. Cetin, S. Aydinlik, T. Bagci-Onder, S. Tekin, H. Demirci, M. Guzel, A. Akdemir, S. Calis, , Y. Yumak

This paper shows Montelukast inhibits SARS-CoV-2 by targeting both Spike/ACE2 and main protease through in silico and in vitro studies.

bioRxiv · Dec 26, 2020Biophysics